Ascendis Pharma A/S Current Assets
Ascendis Pharma A/S (ASND) had Current Assets of EUR 1.11 billion as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-02-11
- 2025-12-31: Current Assets 1.11B EUR.
- 2025-09-30: Current Assets 1.02B EUR.
- 2025-06-30: Current Assets 952.96M EUR.
- 2025-03-31: Current Assets 921.49M EUR.
| Period end | Current Assets |
|---|---|
| 2025-12-31 | 1.11B EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 1.02B EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 952.96M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 921.49M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 1.06B EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 973.74M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 627.32M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 664.11M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 702.72M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 732.92M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 677.68M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 809.85M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 923.47M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 923.47M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 1.08B EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 1.11B EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 1.12B EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 805.89M EUR 20-F · filed 2023-02-16 |
| 2021-09-30 | 956.59M EUR 6-K · filed 2021-11-10 |
| 2021-06-30 | 584.25M EUR 6-K · filed 2021-08-27 |
| 2021-03-31 | 687.27M EUR 6-K · filed 2021-05-27 |
| 2020-12-31 | 740.13M EUR 20-F · filed 2022-03-02 |
| 2020-09-30 | 953.60M EUR 6-K · filed 2020-11-12 |
| 2020-06-30 | 491.62M EUR 6-K · filed 2020-08-27 |
| 2020-03-31 | 551.57M EUR 6-K · filed 2020-05-19 |
| 2019-12-31 | 611.17M EUR 20-F · filed 2021-03-10 |
| 2019-09-30 | 669.65M EUR 6-K · filed 2019-11-18 |
| 2019-06-30 | 702.83M EUR 6-K · filed 2019-08-28 |
| 2019-03-31 | 715.77M EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 292.91M EUR 20-F · filed 2020-04-03 |
| 2018-09-30 | 326.99M EUR 6-K · filed 2018-11-28 |
| 2018-06-30 | 361.66M EUR 6-K · filed 2018-08-29 |
| 2018-03-31 | 357.76M EUR 6-K · filed 2018-05-30 |
| 2017-12-31 | 204.63M EUR 20-F · filed 2019-04-03 |
| 2016-12-31 | 183.96M EUR 20-F · filed 2018-03-28 |